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Introduction 
Cryptosporidium parvum is an intestinal 
parasitic protozoa which causes self-limited 
diarrhoea in immunocompetent individuals 
and devastating and fulminant diarrhoea in 
immunocompromised patients (Griffiths, 
1998). 
Despite extensive effort in searching for 
chemotherapeutic agents against 
cryptosporidiosis, it remains elusive. The 
major impediment in the use of a promising 
chemotherapeutic compound is the intrinsic 
multidrug resistance exhibited by C. parvum 
towards an array of drugs that is generally 
effective against similar organisms (Chen et 
al. 2002). It is postulated that the intrinsic 
multidrug resistance of C. parvum is mediated 
by a general transporting mechanism, possibly 
by the ATP-binding cassette (ABC) 
superfamily of transporters.  
The ABC superfamily of transporters, 
which consists of more than 1,000 members, 
is the largest and most widespread protein 
family known to date. The vast majority of its 
members are ATP driven transporters, which 
is responsible of translocating a wide variety 
of compounds across biological membranes 
(Higgins, 1992; Ambudkar et al., 1999).  
Most ABC transporters share a similar 
architecture: a fundamental structure made up 
of four domains. Two of these domains are the 
hydrophobic membrane-spanning domains 
(MSDs), and two other domains are the 
hydrophilic nucleotide-binding domains 
(NBDs). NBDs are evolutionally conserved 
domains, which have considerable sequence 
homologies across the entire family, and the 
homologies range from 30% to 50%. Two 
NBDs within a transporter show higher 
similarity to each other than to the respective 
domains from other member of transporter 
(Higgins, 1992; Ambudkar et al., 1999). 
In addition to their physiological functions, 
ABC proteins have enormous medical 
relevance. Members of the superfamily, the 
Multidrug resistance protein (MDR) (Juliano 
and Ling, 1976) and Multidrug resistance  
 
associated protein (MRP) (Cole and Deeley, 
1993), are almost always associated with the 
multidrug resistance phenomenon exhibited 
by many intrinsic or acquired drug resistance 
cancer cell lines or human pathogens 
(Davidson, 2002). Transfection studies and 
investigation on the drug sensitive partial 
revertant cell lines clearly elaborated the 
correlation between MDR, MRP and 
multidrug resistance phenotypes (Gao et al., 
1998). 
The present study aims to explore and 
characterise the possible mechanisms 
underlying the MDR characteristic of C. 
parvum by detecting the presence of ABC 
transporter protein encoding genes, especially 
one that shows high similarity to members 
belonging to the MDR and MRP subfamilies 
of transporters.  
 
Materials and methods 
 
Cryptoporidium parvum genomic DNA 
extraction 
C. parvum oocysts (IOWA isolate, bovine 
genotype) used in this study were purchased 
from Waterborne Inc, USA. Genomic DNA 
was extracted from C. parvum oocysts by 
using the QIAamp DNA blood mini kit 
(QIAGEN, Germany). 
 
Degenerate primer for PCR amplification of 
ABC transporter encoding genes 
PCR approach using degenerate primers, 
was used to identify ABC transporter 
encoding gene in C. parvum. The sense and 
antisense primers corresponding to peptide 
GCGKST(L/I)(I/L) and (G/A)(V/S)KLSGGQ 
were selected based on the analysis of the 
highly conserved NBDs of several ABC 
transporter proteins (Dallagiovanna et al., 
1994). The degeneracy of the primers was 
adjusted to account for the codon bias found 
for C. parvum genes. 
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 PCR amplification of ABC transporter 
encoding genes 
The amplification of C. parvum ABC 
transporter protein genes involved two rounds 
of PCR, namely the primary and secondary 
amplifications. In primary amplification, 
degenerate primers were incubated with C. 
parvum genomic DNA, according to standard 
protocol, in a volume of 20µl. The optimum 
PCR annealing temperature was 55oC. The 
secondary PCR amplification condition was 
identical to the first round, except that 1 µl of 
50X diluted primary PCR products was used 
as DNA template. 
 
PCR product purification and cloning 
The QIAquick gel extraction kit 
(QIAGEN, Germany) was used to extract 
DNA bands from agarose gels. Purified PCR 
products were cloned into pGEM®-T vectors 
(Promega, USA), and transformed into JM109 
E. coli (Promega, USA). 
 
Sequencing analyses 
 The resultant positive clones were 
sequenced in both directions on an ABI 
PRISM® 377 DNA sequencer (BST Techlab, 
Singapore). Sequencing primers used were T7 
forward and SP6 reverse promoter primer 
encoded on the pGEM-T vector. 
 Nucleotide and amino acid sequences were 
compared with the sequences deposited in 
NCBI databases via the Blast server. Multiple 
alignments of DNA and protein sequences 
were performed using ClustalW programme. 
Protein similarities were calculated using the 
GeneDoc sequence editor. Conservative 
amino acids are grouped as: 
(D,E,N,Q,H)(S,A,T)(K,R)(F,Y)(L,I,V,M). 
The aligned protein sequences were 
analysed by distance based neighbour-joining 
method, using the Njplot programme. 
Bootstrap replicates of 1000 was set to assess 
the reliability of the tree. An unrooted tree 
was also constructed by using the Njplot. 
 
Results and Discussion 
 PCR using ABC-specific degenerate 
primers successfully amplified two unique 
fragments from C. parvum genomic DNA. 
Sequencing of the fragments revealed two 
partial open reading frames (ORFs). ORF1 
was constituted by 279bp, which encoded a 
peptide of 96 amino acids. ORF2 was 303bp 
in length and encoded a 101-amino acid 
peptide. Comparisons of ORF1 and ORF2 to 
the protein sequences in NCBI databases 
indicated that both fragments exhibited 
significant high similarities to the NBDs of a 
variety of ABC transporters. Thus, ORF1 and 
ORF2 were respectively designated Cpnbd1 
and Cpnbd2. For protein sequences, there 
were designated as Cpnbd1 and Cpnbd2 
[Figure 1(a) and (b)].  
 
Comparisons of Cpnbd1 and Cpnbd2 with 
the NBDs of C. parvum ABC proteins 
At amino acids level, Cpnbd1 was 100% 
identical to the NH2-terminal half (_N) of 
CpABC1, an ABC protein characterised in C. 
parvum KSU-1 isolate (bovine genotype) 
(Zapata et al., 2002). At nucleotide level, both 
gene fragments showed 99% identity. The 
difference was due to a single nucleotide 
changed.  The nucleotide substitution, which 
was at the third position of the codon-33 was a 
silent change as both CAG99 in Cpnbd1 and 
CAA99 in CpABC1_N codes for the amino 
acid glutamine (data not showed).  
Cpnbd1 also showed high similarity to the 
NBD at the NH2-terminal of CpABC. CpABC 
was the gene encoding the ABC protein of C. 
parvum of SFGH1 isolate, an isolate of human 
genotype (Perkin et al., 1999). Both proteins 
were 97% and 98% identical at amino acid 
and nucleotide levels, respectively, and the 
differences were attributed by four nucleotide 
substitutions. Two of the nucleotide 
substitutions resulted in silent changes: CAG99 
at codon-33 of Cpnbd1 and CAA99 of CpABC-
_N, which codes for glutamine, and GAT174 at 
codon-58 of Cpnbd1 and GAC174 of 
CpABC_N, which codes for aspartic acid. 
Two other nucleotide substitutions, which 
occurred at the first position of the 
corresponding codons, resulted in amino acid 
changes. These were the 64ATT at codon-22 of 
Cpnbd1, which codes for isoleucine, and the 
corresponding codon 64GGT at CpABC_N, 
which codes for valine. Whereas at codon-42, 
124GTT of Cpnbd1 coding for valine while 
124ATT of CpABC_N coding for isoleucine 
(data not showed).  
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(a) Cpnbd1/Cpnbd1 
 
ggatgtggtaaatcaacattgattgaacttatattacaagaacttaaaccaagattaggaacaattcaatca 
 G  C  G  K  S  T  L  I  E  L  I  L  Q  E  L  K  P  R  L  G  T  I  Q  S   
aatggttcagttttttattgttcacagtcatcatggattattaatggtacagttagaagtaatattatactt 
 N  G  S  V  F  Y  C  S  Q  S  S  W  I  I  N  G  T  V  R  S  N  I  I  L   
gatttaccttttgatcaagcctggtatgatattgttattaatgcttgttcattagtttatgatttaaaagct 
 D  L  P  F  D  Q  A  W  Y  D  I  V  I  N  A  C  S  L  V  Y  D  L  K  A   
atgccaaatggggatttaacagaaattggtgaaaatggtgttaaactttctggaggtcaa 
 M  P  N  G  D  L  T  E  I  G  E  N  G  V  K  L  S  G  G  Q 
 
(b) Cpnbd2/Cpnbd2 
 
ggatgtggtaaatctacacttataaagcaaatgattggttttattaagcctgatcagggagatgttcactac 
 G  C  G  K  S  T  L  I  K  Q  M  I  G  F  I  K  P  D  Q  G  D  V  H  Y   
ggagatatttcttttatacataaccgtaaacaagctcgaacaatgatgagttatatgtcacaacagtatgca 
 G  D  I  S  F  I  H  N  R  K  Q  A  R  T  M  M  S  Y  M  S  Q  Q  Y  A   
cctcttgaaaagttaactgttgagcaaaatttagagatgattggaagaatgagagggttaagtacctcagaa 
 P  L  E  K  L  T V  E  Q  N  L  E  M  I  G  R  M  R  G  L  S  T  S  E   
ctccaaaaagaaattgagcaccttctagcagatctggaaatagtagaataccgtgataaaaaaggaagtaaa 
 L  Q  K  E  I  E  H  L  L  A  D  L  E  I  V  E  Y  R  D  K  K  G  S  K  
ctttcaggaggacaa  
 L  S  G  G  Q 
 
FIGURE 1 Nucleotide and deduced amino acid sequences of (a) Cpnbd1/Cpnbd1 and (b) Cpnbd2/Cpnbd2. 
Nucleotide sequences are indicated by small letters. Whereas the putative amino acid sequences are 
indicated by capital letters and are represented by single-letter codes. The regions of which the primers 
correspond are underlined.  
 
 
The high degree of similarities between 
Cpnbd1, CpABC and CpABC1 implied that 
they could be encoded by homologous genes 
of a type of ABC transporter protein found in 
different C. parvum isolates.   
As for Cpnbd2, it showed moderate 
similarities to the NBDs at both NH2- and 
COOH-terminal halves of ABC proteins 
characterised in C. parvum to date (Table 1). 
Therefore, Cpnbd2 could be a novel member 
of an ABC superfamily of proteins in C. 
parvum. 
 
Comparisons of Cpnbd1 and Cpnbd2 with 
the NBDs of ABC proteins characterised in 
drug resistance cells 
Phylogenetic analysis on a list of ABC 
transporters known to associate with MDR 
phenotype (EhPGP 5: Entamoeba histolytica 
P-gp-like transporters 5; EhPGP 6: E. 
histolytica P-gp-like transporters 6; 
HuABCB1: Homo sapien ATP-binding 
cassette B1; HuABCC1: H. sapien ATP-
binding cassette C1; HuABCC2: H. sapien 
ATP-binding cassette C2; LaMDR1: 
Leishmania amazonensis Multidrug resistance 
protein 1; Ldmdr1: L. donovani Multidrug 
resistance protein 1; LeMDR1: L. enrietti 
Multidrug resistance protein-like 1; TbMRPA: 
Trypanosoma brucei Multidrug resistance 
protein A; and TbMRPE: T. brucei Multidrug 
resistance protein E) has strongly related 
Cpnbd1 to HuABCC1 and HuABCC2. 
HuABCC1 was a human MRP transporter 
identified in the H69AR doxorubicin-selected 
human lung carcinoma cell line (Mirski et al., 
1987). In normal tissue, HuABCC1 was found 
ubiquitously expressed at low levels. Certain 
normal tissues, however, do highly express 
HuABCC1 at cellular levels. In human cancer 
cells, HuABCC1 was found overexpressed in 
various cancer types. In certain cancer types, 
HuABCC1 expression is an important 
predictor of treatment outcome. The 
expression of HuABCC1 is usually highest in 
tumours that derived from tissues that 
normally express the transporter protein, and 
tumours arising from these tissues are known 
to be intrinsically resistant against 
chemotherapeutic treatment (Cole et al., 1994; 
Hipfner et al., 1999).  
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FIGURE 2 Comparisons of the amino acid sequences of Cpnbd1 and the NBDs of ABC proteins from 
Cryptosporidium parvum and from Homo sapiens. Similar amino acids shared by all, 70% and 50% of the 
aligned sequences, are boxed by black, dark grey and light grey, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3 Comparisons of the amino acid sequences of Cpnbd2 and the NBDs of ABC proteins from 
Cryptosporidium parvum, Homo sapiens and Trypanosoma cruzi. Similar amino acids shared by all and two 
of the aligned sequences, are boxed by black and dark grey, respectively. 
 
 
HuABCC2 is the second member 
identified in the now nine-member MRP 
subfamily of transporter in human. 
Taniguchi et al. (1996) successfully isolated 
the HuABCC2 encoding gene from a 
cisplatin-resistant human cancer cell line. 
The research group also reported a good 
correlation between cisplatin resistance and 
the up-regulation expression of HuABCC2. 
HuABCC2 has been detected in the liver, 
kidneys, intestine, placenta and the brain at 
normal level. HuABCC2 is believed to play 
an important role in eliminating endogenous 
toxic compounds and xenobiotics from the 
body. In hepatocytes, the expression of 
HuABCC2 is markedly increased by various 
chemical carcinogen and chemopreventive 
agents (Payen et al., 2002). Meanwhile, 
intestinal HuABCC2 could play a role in 
reducing the level of 2-amino-1-methyl-6-
phenylimidazo [4,5-6] pyridine; the most 
abundant food derived carcinogen, which is 
formed during cooking, frying and grilling 
of meat (Dietrich et al., 2001).  
The relationship of Cpnbd2 with the 
same group of transporters was less distinct. 
It was clustered in the clade, which consisted 
of the NBDs of various ABC transporter 
proteins (Figure 4). The similarities of 
Cpnbd2 to these NBDs were generally 
            
            
Cpnbd2    : 
HuABCA5_N : 
TcABCA1_N : 
            
                                                       
    *   10    *   20    *   30    *   40    *   50    *
GCGKSTLIKQMIGFIKPDQG-DVHYG-DISFIHNRKQARTMMSYMSQQYAPLEKL
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TVRSNIILDLP-FDQAWYDIVINACSLVYDLKAMPNGDLTEIGENGINLSGGQ
SVRSAILLGRE-WNREKYELIVDCCQLKEDFSSWQRGDLRVVDEGGCSLSGGQ
TIRQNILYGNENATEKEIENALRLSQAWDFVNSFRDGLETLVGNEGGLLSGGQ
SLRENILFGCQ-LEEPYYRSVIQACALLPDLEILPSGDRTEIGEKGVNLSGGQ
TIKDNILFGTE-FNEKRYQQVLEACALLPDLEMLPGGDLAEIGEKGINLSGGQ
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 moderate (Table 1). Interestingly, Cpnbd2 
did show significant high similarity to the 
NBDs at the NH2-terminal halves of two 
ABC proteins [the H. sapien ATP-binding 
cassette A5 (HuABCA5) and T. cruzi 
ABCA1 transporter (TcABCA1)]. It was 
65% similar to HuABCA5_N and 59% 
similar to TcABCA1_N. However, neither 
the substrate nor the function of HuABCA5 
and TcABCA1 is known (Dean et al., 
2001; Torres, 2000). The possible function 
of Cpnbd2, therefore, cannot be inferred 
from the phylogenetic analyses. 
 
TABLE 1. Quantitative analysis of amino acid 
similarities between Cpnbd1, Cpnbd2 and the 
NBD at the  NH2-terminal half and COOH-
terminal half of the ABC proteins of several 
drug resistance parasitic protozoan and Homo 
sapiens.  Chemically similar amino acids were 
defined as: (D,E,N,Q,H) (S,A,T) (K,R) (F,Y) 
(L,I,V,M).  
 
 Similarity (%) 
 Cpnbd1 Cpnbd2 
CpABC_N 100 30 
CpABC_C 46 43 
CpABC1_N 100 30 
CpABC1_C 46 46 
CpABC2_N 58 28 
CpABC2_C 40 49 
CpABC3_N 37 36 
CpABC3_C 41 35 
EhPGP5_N 43 36 
EhPGP5_C 37 36 
EhPGP6_N 30 37 
EhPGP6_C 40 32 
HuABCA5_N Nil 65 
HuABCB1_N 35 39 
HuABCB1_C 36 33 
HuABCC1_N 68 32 
HuABCC1_C 36 41 
HuABCC2_N 68 32 
HuABCC2_C 39 34 
LaMDR1_N 37 36 
LaMDR1_C 41 30 
Ldmdr1_N 37 36 
Ldmdr1_C 42 30 
LeMDR1_N 36 35 
LeMDR1_C 40 31 
TbMRPA_N 59 39 
TbMRPA_C 36 37 
TbMRPE_N 60 38 
TbMRPE_C 39 39 
TcABCA1_N Nil 54 
 
 
The study of ABC protein family in C. 
parvum is considered at its infancy as no 
functional study was thus far been conducted 
on any of the structural characterised ABC 
proteins of the parasite. In intracellular 
stages, CpABC1 was found exclusively at 
the host-parasite boundary of mature 
meronts.  
 
FIGURE 4 The phylogenetic relationship of 
NBDs among various ABC superfamily of 
proteins. 
 
 
The location of CpABC1 suggested that it 
could be a component of one or more of the 
membranes (the meront plasma membrane, 
the parasitophorous vacuole membrane, and 
the feeder organelle) at the host-parasite 
boundary (Zapata et al., 2002). Back in 
1999, similar observation was reported by 
Perkin et al. on CpABC. The peculiar 
location of CpABC and CpABC1, suggested 
that they could play a role in metabolic 
interaction between the parasites and the 
infected host. The localisation of both 
proteins also correlates well and support a 
role as drug efflux pumps that could 
transport endogenous and xenobiotic away 
from the parasites.  
Since some genes of the P-gp and MRP 
subfamilies of transporters have been 
associated with MDR phenomenon in cancer 
patients and certain drug resistance 
pathogens, the presence of such homologous 
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 protein in C. parvum could also attribute to 
the intrinsic MDR phenotype of the parasite. 
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